Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Opt-out prenatal HIV testing in Newfoundland and Labrador

Christa L. Mossman and Samuel Ratnam
CMAJ September 17, 2002 167 (6) 630-630-a;
Christa L. Mossman
*Department of Family Medicine, Memorial University of Newfoundland, St. John's, Nfld.; †Newfoundland Public Health Laboratory, St. John's, Nfld.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel Ratnam
*Department of Family Medicine, Memorial University of Newfoundland, St. John's, Nfld.; †Newfoundland Public Health Laboratory, St. John's, Nfld.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

We read with interest the conclusions of a recent research letter by Ari Bitnun and coauthors1 and the supporting commentary by Kathleen Steel O'Connor and Susan MacDonald.2 Although we concur with the recommendation for prenatal HIV screening on an opt-out basis, both articles seem to imply that this is not being offered in Canada. In fact, Newfoundland and Labrador was the first province in the country to recommend routine prenatal HIV testing in 1992 and also to introduce it on an opt-out basis in 1997.

Based on a province-wide anonymous prenatal HIV prevalence study,3 in 1992 the Department of Health recommended that HIV testing be considered as part of routine prenatal care. During 1993, it was estimated that nearly half of pregnant women in the province underwent HIV testing, rising subsequently to two-thirds. A second prevalence study in 1996 indicated that HIV testing done on a voluntary basis might not include all those at risk for HIV. Consequently, in 1997 HIV testing was introduced across the province on an opt-out basis (long before such a recommendation was made by the US Institute of Medicine4). Currently, 94% of pregnant women are being screened for HIV status (internal data).

Since 1992, our prenatal screening program has identified a few HIV-positive pregnant women, with no cases of vertically transmitted HIV infection in children born after 1994. However, our province has a low HIV prevalence; therefore, prenatal screening on an opt-out basis may be more effective and beneficial in populations with a higher prevalence.

Christa L. Mossman Department of Family Medicine Memorial University of Newfoundland St. John's, Nfld. Samuel Ratnam Newfoundland Public Health Laboratory St. John's, Nfld.

References

  1. 1.↵
    Bitnun A, King SM, Arneson C, Read SE. Failure to prevent perinatal HIV infection. CMAJ 2002; 166(7):904-5.
    OpenUrlFREE Full Text
  2. 2.↵
    Steel O'Connor K, MacDonald SE. Aiming for zero: preventing mother-to-child transmission of HIV. CMAJ 2002;166(7):909-10.
    OpenUrlFREE Full Text
  3. 3.↵
    Ratnam S, Hogan K, Hankins C. Prevalence of HIV infection among pregnant women in Newfoundland. CMAJ 1996;154(7):1027-32.
    OpenUrlAbstract
  4. 4.↵
    Institute of Medicine, Committee on Perinatal Transmission of HIV and Commission on Behavioral and Social Sciences and Education. Reducing the odds: preventing perinatal transmission of HIV in the United States. Washington: National Academy Press; 1999.
PreviousNext
Back to top

In this issue

CMAJ
Vol. 167, Issue 6
17 Sep 2002
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Opt-out prenatal HIV testing in Newfoundland and Labrador
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Opt-out prenatal HIV testing in Newfoundland and Labrador
Christa L. Mossman, Samuel Ratnam
CMAJ Sep 2002, 167 (6) 630-630-a;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Opt-out prenatal HIV testing in Newfoundland and Labrador
Christa L. Mossman, Samuel Ratnam
CMAJ Sep 2002, 167 (6) 630-630-a;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Hospital-at-home programs in Canada: challenges and pitfalls
  • Author response to “Pitfalls of analyzing perinatal outcomes by health care provider”
  • Pitfalls of analyzing perinatal outcomes by health care provider
Show more Letters

Similar Articles

Collections

  • Topics
    • HIV & AIDS
    • Maternal-fetal medicine
    • Screening & diagnostic tests

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

CMA Civility, Accessibility, Privacy

 

Powered by HighWire